Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 542-548

  Keatings, Vera M ^a   Jatakanon, Anon ^a   Worsdell, Y Miin ^a   Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; EOSINOPHIL CATIONIC PROTEIN; GLUCOCORTICOID; INTERLEUKIN 8; LIPOCALIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AIRFLOW; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG RESISTANCE; FEMALE; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE ACTIVATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SPUTUM ANALYSIS; SYMPTOMATOLOGY;

EID: 0031045482     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032192     Document Type: Article

References (34)

1. Fletcher, C., R. Peto, C. Tinker, and F. E. Speizer. 1976. The Natural History of Chronic Bronchitis and Emphysema. An Eight Year Study of Early COPD in Working Men in London. Oxford University Press, Oxford.
2. 1. The Lung Health Study. J.A.M.A. 272:1497-1505.
3. MRC Working Party. 1981. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet i:681-686.
4. Djukanovic, R., W. R. Roche, J. W. Wilson, C. R. W. Beasley, O. P. Twentyman, P. H. Howarth, and S. T. Holgate. 1990. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:434-457.
5. Wardlaw, A. J., S. Dunette, G. J. Gleich, J. V. Collins, and A. B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.
6. Saetta, M., A. Di Stefano, P. Maestrelli, A. Ferraresso, R. Drigo, A. Potena, A. Ciaccia, and L. M. Fabbri. 1993. Activated T lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am. Rev. Respir. Dis. 147:301-306.
7. Mullen, J. B. M., J. L. Wright, B. R. Wiggs, P. D. Páre, and J. C. Hogg. 1985. Reassessment of airways inflammation in chronic bronchitis. B.M.J. 291:1235-1239.
8. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. J. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant Th2-like bronchoalveolar T lympohocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
9. Kwon, O. J., P. Jose, R. A. Robbins, T. J. Schall, T. J. Williams, and P. J. Barnes. 1995. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 12: 488-496.
10. Robinson, D., Q. Hamid, S. Ying, A. Bentley, B. Assoufi, S. Durham, and A. B. Kay. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5 and interferon-gamma cytokine gene expression. Am. Rev. Respir. Dis. 148:401-406.
11. Barnes, P. J., and I. Adcock. 1993. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 14:436-441.
12. Martin, T. R., G. Raghu, R. J. Maunder, and S. C. Springmeyer. 1985. The effects of chronic bronchitis and chronic airflow obstruction on lung cell populations recovered by broncho-alveolar lavage. Am. Rev. Respir. Dis. 132:254-260.
13. Thompson, A. B., D. Daughton, G. A. Robbins, M. A. Ghafouri, M. Oehlerking, and S. I. Rennard. 1989. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am. Rev. Respir. Dis. 140:1527-1537.
14. Finklestein, R., R. S. Fraser, H. Ghezzo, and M. G. Cosio. 1995. Alveolar inflammation and its relation to emphysema in smokers. Am. J. Respir. Crit. Care Med. 152:1666-1672.
15. De Stefano, A., P. Maestrelli, A. Roggeri, G. Turato, S. Calabro, A. Potena, C. E. Mapp, A. Ciaccia, L. Covacev, L. M. Fabbri, and M. Saetta. 1994. Upregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitis. Am. J. Respir. Crit. Care Med. 149:803-810.
16. Riise, G. C., S. Larsson, C.-G. Lofdahl, and B. Andersson. 1994. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur. Respir. J. 7:1673-1677.
17. Keatings, V. M., P. D. Collins, D. M. Scott, and P. J. Barnes. 1996. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease and asthma. Am. J. Respir. Crit. Care Med. 153:530-534.
18. Smith, W. B., J. R. Gamble, I. Clarke-Lewis, and M. A. Vadas. 1991. 1L-8 induces neutrophil transendothelial migration. Immunology 72:65-72.
19. Pober, J. S., M. A. Gimbrone, L. A. Lapierre, D. L. Mendrick, W. Fiers, R. Rothlein, and T. A. Springer. 1986. Overlapping patterns of activation of human endothelial cells by interleukin-1 tumor necrosis factor-alpha and immune interferon. J. Immunol. 137:1893-1896.
20. Keatings, V. M., and P. J. Barnes. 1995. Concentrations of ECP are increased in COPD but these are not modified by treatment with inhaled corticosteroids (abstract). Thorax 50:A33.
21. Barnes, P. J., and S. Pedersen. 1993. Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. Am. Rev. Respir. Dis. 148:S1-S26.
22. American Thoracic Society Statement. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152:S77-S124.
23. Siafakas, N. M., P. Vermiere, N. B. Pride, P. Poaletti, J. Gibson, P. Howard, J. C. Yernault, M. Decramer, T. Higgenbottam, D. S. Postma, and J. Rees. 1995. Optimal assessment and management of chronic obstructive pulmonary disease. Eur. Respir. J. 8:1398-1420.
24. Pauwels, R. A., C. G. Lofdahl, N. B. Pride, D. S. Postma, L. A. Laitinen, and S. V. Ohlsson. 1992. European Respiratory Society study on COPD (EUROSCOP): hypothesis and design. Eur. Respir. J. 5: 1254-1261.
25. Wier, D. C., and P. S. Burge. 1993. Effects of high dose inhaled beclomethasone dipropionate, 750 μg and 1500 μg twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic airflow obstruction. Thorax 48:309-316.
26. Postma, D. S., E. J. Steenhuis, L. T. van der Weele, and H. J. Sluiter. 1985. Severe chronic airflow obstruction: can corticosteroids slow down progression? Eur. J. Respir. Dis. 67:56-64.
27. Postma, D. S., I. Peters, E. J. Steenhuis, and H. J. Sluiter. 1988. Moderately severe chronic airflow obstruction: can corticosteroids slow down obstruction? Eur. Respir. J. 1:22-26.
28. Wiggins, J., J. A. Elliott, R. D. Stevenson, and R. A. Stockley. 1982. Effect of corticosteroids on sputum sol phase protease inhibitors in COPD. Thorax 37:652-656.
29. Collins, P. D., P. J. Jose, and T. J. Williams. 1991. The sequential generation of neutrophil chemoattractant proteins in the rabbit in vivo: relationship between C5a and proteins with the characteristics of IL-8/neutrophil activating protein. J. Immunol. 146:677-682.
30. Claman, D. A., H. A. Boushey, J. Liu, H. Wong, and J. V. Fahy. 1994. Analysis of induced sputum to examine the effects of prednisolone on airway inflammation in asthmatic subjects. J. Allergy Clin. Immunol. 94:861-869.
31. Oddera, S., M. Silvestri, O. Sacco, S. Lantero, M. C. Morelli, and G. A. Rossi. 1995. Evaluation of the inhibitory effects of budesonide on the mitogen-induced or the allergen-induced activation of blood mononuclear cells isolated from asthmatic patients. Ann. Allergy Asthma Immunol. 75:33-40.
32. Kwon, O. J., B. T. Au, P. D. Collins, I. M. Adcock, J. C. Mak, R. A. Robbins, J. M. Baranuik, K. F. Chung, and P. J. Barnes. 1994. Tumor necrosis factor-induced interleukin-8 expression in cultured human pulmonary epithelial cells: regulation by dexamethasone. Am. J. Physiol. 11:L398-L405.
33. Schleimer, R. P., and B. S. Bochner. 1994. The effects of glucocorticoids on human eosinophils. J. Allergy Clin. Immunol. 94:1202-1213.
34. Cox, G. 1995. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154(9):4719-4725.